| SDAX P-IN. | 12,451.69 / +0.96% |
| Date/Time | 12/13 / 17:45 |
| Chg. / Chg.(%) | 118.08 / +0.96% |
| Open | 12,467.37 |
| Previous Close | 12,333.61 |
| High | 12,543.73 |
| Low | 12,406.28 |
| ISIN | DE0009653386 |
| Security | SDXP |
| Type | Index |
News
- PTA-News: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
02/26/2019 / 12:36 - pressetext - PTA-Adhoc: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
02/26/2019 / 12:35 - pressetext - PTA-News: Medigene AG: Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe
02/26/2019 / 07:30 - pressetext - PTA-News: Medigene AG: European Patent covering TCR library suitable for the development of neoantigen-specific TCRs
02/25/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at upcoming conferences
02/22/2019 / 07:30 - pressetext
Real-time